- Home
- REE vs PASG Comparison
REE vs PASG Comparison
Compare REE & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- PASG
- Stock Information
- Founded
- REE 2011
- PASG 2017
- Country
- REE Israel
- PASG United States
- Employees
- REE N/A
- PASG N/A
- Industry
- REE Auto Manufacturing
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- PASG Health Care
- Exchange
- REE Nasdaq
- PASG Nasdaq
- Market Cap
- REE 18.5M
- PASG 20.3M
- IPO Year
- REE N/A
- PASG 2020
- Fundamental
- Price
- REE $0.76
- PASG $7.44
- Analyst Decision
- REE Strong Buy
- PASG Strong Buy
- Analyst Count
- REE 2
- PASG 3
- Target Price
- REE $11.75
- PASG $153.33
- AVG Volume (30 Days)
- REE 129.4K
- PASG 100.2K
- Earning Date
- REE 09-25-2025
- PASG 08-07-2025
- Dividend Yield
- REE N/A
- PASG N/A
- EPS Growth
- REE N/A
- PASG N/A
- EPS
- REE N/A
- PASG N/A
- Revenue
- REE $183,000.00
- PASG N/A
- Revenue This Year
- REE $6,661.20
- PASG N/A
- Revenue Next Year
- REE $2,240.01
- PASG N/A
- P/E Ratio
- REE N/A
- PASG N/A
- Revenue Growth
- REE N/A
- PASG N/A
- 52 Week Low
- REE $0.53
- PASG $5.12
- 52 Week High
- REE $11.72
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- REE 49.95
- PASG 53.78
- Support Level
- REE $0.67
- PASG $5.12
- Resistance Level
- REE $0.80
- PASG $5.99
- Average True Range (ATR)
- REE 0.05
- PASG 0.88
- MACD
- REE 0.04
- PASG -0.03
- Stochastic Oscillator
- REE 77.06
- PASG 58.25
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.